KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Payables (2016 - 2026)

Pfizer has reported Payables over the past 18 years, most recently at $4.5 billion for Q1 2026.

  • Quarterly Payables fell 14.01% to $4.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.5 billion through Mar 2026, down 14.01% year-over-year, with the annual reading at $7.7 billion for FY2025, 4.77% down from the prior year.
  • Payables was $4.5 billion for Q1 2026 at Pfizer, down from $7.7 billion in the prior quarter.
  • Over five years, Payables peaked at $9.1 billion in Q4 2022 and troughed at $4.5 billion in Q1 2026.
  • The 5-year median for Payables is $7.5 billion (2024), against an average of $6.9 billion.
  • Year-over-year, Payables skyrocketed 35.48% in 2022 and then tumbled 37.29% in 2023.
  • A 5-year view of Payables shows it stood at $9.1 billion in 2022, then fell by 0.33% to $9.1 billion in 2023, then decreased by 11.14% to $8.1 billion in 2024, then fell by 4.77% to $7.7 billion in 2025, then crashed by 41.37% to $4.5 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Payables are $4.5 billion (Q1 2026), $7.7 billion (Q4 2025), and $5.0 billion (Q3 2025).